COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05323331


Column Value
Trial registration number NCT05323331
Full text link
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

https://clinicaltrials.gov/show/NCT05323331

First author
Last imported at : Jan. 6, 2023, 8 p.m.
Source : ClinicalTrials.gov

Not reported

Contact
Last imported at : Jan. 6, 2023, 8 p.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

2022-04-12

Recruitment status
Last imported at : Jan. 6, 2023, 8 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: middle age adults (40-60 years), medically stable, but previously diagnosed with cardiac diseases. patients who have recovered recently from covid-19 (6-8 weeks post-discharge). oxygen saturation levels are maintained above 92% at rest and during exercise. heart rate should not be elevated more than 20 beats per minute as per the calculated heart rate range (if the patient is on beta-blockers, that should be kept in consideration) systolic blood pressure should be ≥90 mmhg and ≤180 mmhg. symptoms of dyspnea: borg scale >4 fatigue: rate of perceived exertion (rpe) >11-12 exclusion criteria there are signs of active infection/systemic illness going on, presence of fatigue and breathlessness even at rest. participant is febrile (body temperature >38.6degree celsius) oxygen saturation levels below <93%. systolic blood pressure <90 mmhg or >180mmhg. -

Exclusion criteria
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

None

Number of arms
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Riphah International University

Inclusion age min
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

40

Inclusion age max
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

60

Countries
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Pakistan

Type of patients
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

60

primary outcome
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

6 Minutes Walk Test;6 Minutes Walk Test;Post-Covid Functional Status Scale (PCFS);Post-Covid Functional Status Scale (PCFS);Rate of Perceived Exertion (RPE 6-20):;Rate of Perceived Exertion (RPE 6-20):

Notes
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : April 13, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 41, "treatment_name": "Aerobic exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2434, "treatment_name": "Circuit training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}]